These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15774773)

  • 21. [A case report of advanced rectal cancer showing a pathological complete response by neo-adjuvant FOLFOX chemotherapy].
    Murata A; Inoue T; Maeda K; Noda E; Nagahara H; Kubo N; Tanaka H; Muguruma K; Yamada N; Ohira M; Hirakawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2623-5. PubMed ID: 21224659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overcoming the challenges of primary tumor management in patients with metastatic colorectal cancer unresectable for cure and an asymptomatic primary tumor.
    Matsumoto T; Hasegawa S; Matsumoto S; Horimatsu T; Okoshi K; Yamada M; Kawada K; Sakai Y
    Dis Colon Rectum; 2014 Jun; 57(6):679-86. PubMed ID: 24807591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FOLFOX-4 regimen with concomitant highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients: a report of five cases and review of the literature.
    Berretta M; Di Benedetto F; Bearz A; Simonelli C; Martellotta F; Del Ben C; Berretta S; Spina M; Tirelli U
    Cancer Invest; 2008 Jul; 26(6):610-4. PubMed ID: 18584352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxaliplatin in the treatment of colorectal cancer.
    Kim GP; Erlichman C
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):281-94. PubMed ID: 17428157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Safety and efficacy analysis of FOLFOX4 regimen in elderly compared to younger colorectal cancer patients].
    Kuboki Y; Ichimura T; Ogura M; Matsuda M; Suenaga M; Shinozaki E; Matsuzaka S; Chin K; Mizunuma N; Hatake K
    Gan To Kagaku Ryoho; 2008 May; 35(5):781-5. PubMed ID: 18487913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy with oxaliplatin and 5-fluorouracil in a patient with severe hepatic dysfunction associated with metastatic adenocarcinoma of the large bowel.
    Grenader T; Goldberg A; Gabizon A
    Anticancer Drugs; 2009 Oct; 20(9):845-7. PubMed ID: 19633535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.
    Fuchs CS; Marshall J; Mitchell E; Wierzbicki R; Ganju V; Jeffery M; Schulz J; Richards D; Soufi-Mahjoubi R; Wang B; Barrueco J
    J Clin Oncol; 2007 Oct; 25(30):4779-86. PubMed ID: 17947725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
    Oestreicher P
    ONS Connect; 2007; 22(8 Suppl):37-8. PubMed ID: 17824557
    [No Abstract]   [Full Text] [Related]  

  • 29. [Irinotecan in combination with 5-fluorouracil and leucovorin in the treatment of metastatic colorectal cancer].
    Prausová J; Kubácková K; Linke Z; Kubala E; Pipková R; Hladíková J
    Cas Lek Cesk; 2005; 144(11):747-51; discussion 752. PubMed ID: 16335701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome study.
    Matsumoto S; Nishimura T; Kanai M; Mori Y; Nagayama S; Kawamura J; Nomura A; Miyamoto S; Kitano T; Ishiguro H; Yanagihara K; Teramukai S; Sakai Y; Chiba T; Fukushima M
    Chemotherapy; 2008; 54(5):395-403. PubMed ID: 18781065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: preliminary data and future perspectives.
    Adamo V; Franchina T; Minciullo PL; Pace E; Colonese F; Ricciardi GR; Saitta S; Ferraro M; Spatari G; Gangemi S
    J Cell Physiol; 2011 Nov; 226(11):3032-4. PubMed ID: 21302302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer.
    Ashley AC; Sargent DJ; Alberts SR; Grothey A; Campbell ME; Morton RF; Fuchs CS; Ramanathan RK; Williamson SK; Findlay BP; Pitot HC; Goldberg RM
    Cancer; 2007 Aug; 110(3):670-7. PubMed ID: 17559146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bevacizumab in metastatic colorectal cancer and carcino-embryonic antigen kinetics: case report and review of literature.
    de Andrade DP; Lima JP; Lima AD; Sasse AD; dos Santos LV
    Anticancer Drugs; 2011 Jun; 22 Suppl 2():S15-7. PubMed ID: 21768792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Modified FOLFOX6(mFOLFOX6)in metastatic colorectal carcinoma patients with poor performance status].
    Nishi T; Hamamoto Y; Uemoto J; Onodera K; Warita E; Yamanaka Y
    Gan To Kagaku Ryoho; 2012 Dec; 39(13):2557-60. PubMed ID: 23235179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant chemotherapy by FOLFOX for gastric hepatoid adenocarcinoma.
    Velut G; Mary F; Wind P; Aparicio T
    Dig Liver Dis; 2014 Dec; 46(12):1135-6. PubMed ID: 25179158
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
    Ishizuka M; Nagata H; Takagi K; Kubota K
    Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of sequential chemotherapy in the treatment of metastatic colorectal cancer].
    Tassinari D; Tamburini E; Carloni F; Nicoletti S; Ravaioli A
    Recenti Prog Med; 2009 Feb; 100(2):73-9. PubMed ID: 19350798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incomplete operative removal of colorectal liver metastases followed by chemotherapy decreases survival in comparison to chemotherapy alone.
    Popov IP; Milicevic M; Kecmanovic D; Tomasevic Z; Radosevic-Jelic Lj; Borojevic N; Micev MT; Kezic I
    J Exp Clin Cancer Res; 2006 Sep; 25(3):313-9. PubMed ID: 17167970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.
    Lim JY; Cho JY; Oh KJ; Choi SH; Lee SI; Jeung HC
    Chemotherapy; 2009; 55(4):200-6. PubMed ID: 19451710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant chemotherapy with 5-fluorouracil in a patient with colorectal cancer and Familial Mediterranean Fever.
    Purim O; Sulkes A; Brenner B
    Anticancer Drugs; 2007 Jul; 18(6):733-5. PubMed ID: 17762405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.